← Eichor
Condition: Leukopenia Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Leukopenia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia
Phase 1 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06245746A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 L
Phase 1/Phase 2 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05600920Evaluation of the Effect of Cordycepin on CD8+ Lymphocytopenia in Patients With Solid Tumors
Phase 2 · 1 location(s) · Second Affiliated Hospital of Soochow University · NCT07258160Cologne Cohort of Neutropenic Patients (CoCoNut)
Phase N/A · 1 location(s) · University Hospital of Cologne · NCT01821456Short Antibiotic Treatment in High Risk Febrile Neutropenia
NA · 4 location(s) · University Health Network, Toronto · NCT05786495Immunological Effects of Iron Supplementation in HHT Disease
NA · 1 location(s) · Hospices Civils de Lyon · NCT07111598Next-Generation-Sequencing Approach to Neutropenic Sepsis
Phase N/A · 6 location(s) · Boris Böll · NCT05815628Clinical Study of Thiopegfilgrastim for Preventing Bone Marrow Suppression in Thoracic Tumor Chemoradiotherapy
Phase 2 · 1 location(s) · Affiliated Hospital of Nantong University · NCT07205536Prevalence of Ethnic Neutropenia and Duffy Null Phenotype in Neonates
Phase N/A · 1 location(s) · Kaplan Medical Center · NCT06908616Luspatercept for Clonal Cytopenias of Uncertain Significance
Phase 2 · 1 location(s) · Weill Medical College of Cornell University · NCT06788691Phase II Study of QLC2519 in Pediatric Solid Tumor Participants
Phase 2 · 1 location(s) · Qilu Pharmaceutical Co., Ltd. · NCT07724756Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia
Phase 2 · 1 location(s) · West Virginia University · NCT05537896Antibiotic Duration and Outcomes in High-Risk Febrile Neutropenia Patients
NA · 1 location(s) · Valeria Cento · NCT07372131Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00867269Early De-escalation of Empirical Antibiotics Treatment for Neutropenic Fever
NA · 1 location(s) · Shanghai Jiao Tong University School of Medicine · NCT04270786Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood Cancers
NA · 1 location(s) · Alexandria University · NCT07300735Compare the Efficacy and Safety of QL0605 Injections at Different Timepoints
Phase 4 · 1 location(s) · Qilu Pharmaceutical Co., Ltd. · NCT06616571Efficacy of Empirical Anti-Infective Therapy in Neutropenic Febrile Patients.
Phase N/A · 1 location(s) · Shanxi Bethune Hospital · NCT07204522Real-world Study on the Prevention of Neutropenia After Tumor Treatment With Mecapegfilgrastim Injection
Phase N/A · 1 location(s) · Hebei Medical University Fourth Hospital · NCT07434063Breath Analysis for the Detection of Invasive Fungal Infections
Phase N/A · 1 location(s) · University of Zurich · NCT06537726Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Maligna
Phase 4 · 1 location(s) · Gadjah Mada University · NCT07016165Plasma Host-Microbe Proteomics to Predict Complications in High-risk Febrile Neutropenia
Phase N/A · 3 location(s) · Instituto de Investigación Biomédica de Salamanca · NCT07277387Ceftolozane/Tazobactam Versus Meropenem for Febrile Neutropenia on Patients Colonized With or at Risk for Infection With
Phase 4 · 1 location(s) · Beneficência Portuguesa de São Paulo · NCT06342115Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapi
NA · 2 location(s) · Peter MacCallum Cancer Centre, Australia · NCT07051525Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hematological
Phase 2 · 1 location(s) · The First Affiliated Hospital of Xiamen University · NCT06584006Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
Phase N/A · 1 location(s) · Paul Szabolcs · NCT04528355Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemor
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT06181656Predictive Performance of a Generative Model for Corneal Tomography After ICL Implantation
Phase N/A · 1 location(s) · Second Affiliated Hospital of Nanchang University · NCT07146737Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients
Phase 4 · 1 location(s) · Tufts Medical Center · NCT05626530Study of Trilaciclib and Lurbinectidin
Phase 2 · 2 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT05578326
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.